Back

Effects of empagliflozin on skeletal muscle degradation in patients with heart failure: a prospective observational study

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: from diagnosis to treatment Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tatsuya Nishikawa

Akashi Medical Center, Akashi (Japan)

5 More presentations in this session

Presentation thumbnail
Exercise-induced oxygen desaturation reveals early post-discharge vulnerability in heart failure
Doctor I. Sunayama (Nishinomiya, JP)
Abstract
Presentation thumbnail
Derivation of a hierarchical risk structure within the INEEDHELP using classification and regression tree analysis
Doctor T. Osotthanakorn (Phitsanulok, TH)
Abstract
Presentation thumbnail
Geographic variation in the performance of the HFpEF-ABA score: Asia versus outside Asia
Doctor R. Ono (Glasgow, GB)
Abstract
Presentation thumbnail
Magnitude of change in quality of life 60 days after discharge identifies patients at very high risk of readmission or death following hospitalisation for heart failure
Ms M. Mcginlay (Leeds, GB)
Abstract
Presentation thumbnail
Utilization of health care services including specialist palliative care in patients with cardiovascular diseases at the end of life; a nationwide register-based cohort study
Doctor I. Stenstrom (Turku, FI)
Abstract

Access the full session

Session thumbnail
Heart failure: from diagnosis to treatment

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors on temporal change of skeletal muscle index in patients with outpatient cardiac rehabilitation program
3 April 2025
thumbnail
Congress Presentation
Prognostic value of urinary titin N-fragment in patients with heart failure: a retrospective cohort study
28 August 2026
thumbnail
Congress Presentation
Empagliflozin in a real-world chronic heart failure population
3 September 2019
thumbnail
Congress Presentation
Multilevel metabolic impairments in skeletal muscle of heart failure patients
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources